Followers | 561 |
Posts | 39671 |
Boards Moderated | 2 |
Alias Born | 06/08/2006 |
Wednesday, July 20, 2016 10:59:41 AM
Recent KURA News
- Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology • GlobeNewswire Inc. • 09/30/2024 10:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 08:10:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 08:10:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:05:52 PM
- Kura Oncology Appoints Michael Vasconcelles, M.D., to Board of Directors • GlobeNewswire Inc. • 09/17/2024 11:30:00 AM
- Kura Oncology to Participate in Cantor Global Healthcare Conference • GlobeNewswire Inc. • 09/10/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:15:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:10:09 PM
- Kura Oncology Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/08/2024 08:05:00 PM
- Kura Oncology Announces FDA Clearance of IND Application for Menin Inhibitor Ziftomenib in Advanced Gastrointestinal Stromal Tumors (GIST) • GlobeNewswire Inc. • 08/08/2024 11:30:00 AM
- Kura Oncology to Report Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/05/2024 11:30:00 AM
- Kura Oncology Reports Preclinical Data Supporting Potential for Menin Inhibitor in Diabetes • GlobeNewswire Inc. • 06/24/2024 11:30:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/07/2024 08:30:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:30:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:30:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:05:11 PM
- Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 06/07/2024 11:30:00 AM
- Kura Oncology to Participate in Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/29/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:06:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2024 10:30:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/20/2024 08:19:43 PM
- Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Kura Oncology to Participate in Bank of America Securities Healthcare Conference • GlobeNewswire Inc. • 05/08/2024 11:30:00 AM
- Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 05/03/2024 11:30:00 AM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM